biostudies-literatureUnknown1(2)Narang P<h4>Purpose</h4>To evaluate the Advanced Vision Analyzer (AVA; Elisar Vision Technology) and to compare pointwise threshold sensitivity and functional correlation of Elisar Standard Algorithm (ESA) with the Swedish Interactive Threshold Algorithm (SITA) of the Humphrey Field Analyzer (HFA; Carl Zeiss Meditec, Inc).<h4>Design</h4>Prospective, cross-sectional, observational case series.<h4>Participants</h4>One hundred sixty eyes (85 control participants, 75 glaucoma patients) for functional assessment, 15 eyes for test-retest variability (TRV), 107 eyes for blind spot trial (45 normal eyes, 62 glaucoma eyes) were recruited consecutively. A separate group of participants was chosen for each assessment.<h4>Methods</h4>All participants underwent ESA and SITA Standard 24-2 testing, and 1 eye of Ophthalmology science100035https://www.ebi.ac.uk/biostudies/studies/S-EPMC9559955biostudies-literatureAdvanced Vision Analyzer-Virtual Reality Perimeter: Device Validation, Functional Correlation and Comparison with Humphrey Field Analyzer.PMC9559955Narang PAgarwal ASrinivasan MfalseAdvanced Vision Analyzer-Virtual Reality Perimeter: Device Validation, Functional Correlation and Comparison with Humphrey Field Analyzer.<h4>Purpose</h4>To evaluate the Advanced Vision Analyzer (AVA; Elisar Vision Technology) and to compare pointwise threshold sensitivity and functional correlation of Elisar Standard Algorithm (ESA) with the Swedish Interactive Threshold Algorithm (SITA) of the Humphrey Field Analyzer (HFA; Carl Zeiss Meditec, Inc).<h4>Design</h4>Prospective, cross-sectional, observational case series.<h4>Participants</h4>One hundred sixty eyes (85 control participants, 75 glaucoma patients) for functional assessment, 15 eyes for test-retest variability (TRV), 107 eyes for blind spot trial (45 normal eyes, 62 glaucoma eyes) were recruited consecutively. A separate group of participants was chosen for each assessment.<h4>Methods</h4>All participants underwent ESA and SITA Standard 24-2 testing, and 1 eye of 2021-01-01T00:00:00Z2021 Jun2025-04-04T23:01:50.549Z2025-04-04T23:01:50.549ZS-EPMC95599553624930410.1016/j.xops.2021.100035